101 related articles for article (PubMed ID: 17950836)
1. Real-world safety and efficacy of the endeavor zotarolimus-eluting stent: early data from the E-Five Registry.
Jain AK; Meredith IT; Lotan C; Rothman MT; Pateraki S;
Am J Cardiol; 2007 Oct; 100(8B):77M-83M. PubMed ID: 17950836
[TBL] [Abstract][Full Text] [Related]
2. Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.
Gershlick A; Kandzari DE; Leon MB; Wijns W; Meredith IT; Fajadet J; Popma JJ; Fitzgerald PJ; Kuntz RE;
Am J Cardiol; 2007 Oct; 100(8B):45M-55M. PubMed ID: 17950832
[TBL] [Abstract][Full Text] [Related]
3. The relation between clinical features, angiographic findings, and the target lesion revascularization rate in patients receiving the endeavor zotarolimus-eluting stent for treatment of native coronary artery disease: an analysis of ENDEAVOR I, ENDEAVOR II, ENDEAVOR II Continued Access Registry, and ENDEAVOR III.
Mehta RH; Leon MB; Sketch MH;
Am J Cardiol; 2007 Oct; 100(8B):62M-70M. PubMed ID: 17950834
[TBL] [Abstract][Full Text] [Related]
4. Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study.
Meredith IT; Ormiston J; Whitbourn R; Kay IP; Muller D; Popma JJ; Cutlip DE; Fitzgerald PJ;
Am J Cardiol; 2007 Oct; 100(8B):56M-61M. PubMed ID: 17950833
[TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registry.
Lotan C; Meredith IT; Mauri L; Liu M; Rothman MT;
JACC Cardiovasc Interv; 2009 Dec; 2(12):1227-35. PubMed ID: 20129549
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry.
Costa JR; Sousa A; Moreira AC; Costa RA; Maldonado G; Cano MN; Egito ET; Romano ER; Barbosa M; Pavanello R; Jardim C; Cury A; Berwanger O; Sousa JE
J Invasive Cardiol; 2008 Aug; 20(8):404-10. PubMed ID: 18688065
[TBL] [Abstract][Full Text] [Related]
8. One-year outcomes with the Taxus Liberté stent in the real world: the Taxus Olympia registry (phase I).
Ahmed WH; Zambahari R; Al-Rashdan I; Al Naeemi A; Saeed FA; Mascioli S
J Interv Cardiol; 2008 Dec; 21(6):512-8. PubMed ID: 18973513
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients.
Romagnoli E; Leone AM; Burzotta F; Trani C; Angeloni G; Materazzo G; Niccoli G; De Vita M; Perfetti M; Mazzari MA; Mongiardo R; Rebuzzi AG; Schiavoni G; Crea F
J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):589-94. PubMed ID: 18475127
[TBL] [Abstract][Full Text] [Related]
10. Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'.
Jeremias A; Ruisi CP; Kirtane AJ; Lee T; Sylvia B; Pinto DS; Ho KK; Cutlip DE; Carrozza JP; Cohen DJ
Coron Artery Dis; 2008 Mar; 19(2):111-5. PubMed ID: 18300748
[TBL] [Abstract][Full Text] [Related]
11. Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five Registry.
Rothman MT; Jain AK;
Catheter Cardiovasc Interv; 2012 Nov; 80(6):885-92. PubMed ID: 22517785
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTE-Korea registries.
Park KW; Lee JM; Kang SH; Ahn HS; Yang HM; Lee HY; Kang HJ; Koo BK; Cho J; Gwon HC; Lee SY; Chae IH; Youn TJ; Chae JK; Han KR; Yu CW; Kim HS
J Am Coll Cardiol; 2013 Feb; 61(5):536-44. PubMed ID: 23273394
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry.
Sousa A; Costa JR; Moreira AC; Cano M; Maldonado G; Costa RA; Pavanello R; Romano ER; Campos C; Haddad N; Abizaid A; Feres F; Mattos LA; Staico R; Sousa JE;
J Interv Cardiol; 2008 Aug; 21(4):307-14. PubMed ID: 18754966
[TBL] [Abstract][Full Text] [Related]
14. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).
Roy P; Bonello L; de Labriolle A; Okabe T; Pinto Slottow TL; Steinberg DH; Torguson R; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Am J Cardiol; 2008 Aug; 102(3):292-7. PubMed ID: 18638589
[TBL] [Abstract][Full Text] [Related]
15. Extended follow-up safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: two-year follow-up from the E-Five Registry.
Meredith I; Rothman M; Erglis A; Parikh K; Lotan C;
Catheter Cardiovasc Interv; 2011 Jun; 77(7):993-1000. PubMed ID: 20853351
[TBL] [Abstract][Full Text] [Related]
16. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry.
Cuculi F; Banning AP; Abizaid A; Bartorelli AL; Baux AC; Dzavík V; Ellis S; Gao R; Holmes D; Jeong MH; Legrand V; Neumann FJ; Nyakern M; Spaulding C; Stoll HP; Worthley S; Urban P;
EuroIntervention; 2011 Dec; 7(8):962-8. PubMed ID: 22157482
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
19. Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).
Planer D; Beyar R; Almagor Y; Banai S; Guetta V; Miller H; Kornowski R; Brandes S; Krakover R; Solomon M; Lotan C
Am J Cardiol; 2008 Apr; 101(7):953-9. PubMed ID: 18359314
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry).
Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Richardt G;
Am J Cardiol; 2008 Feb; 101(4):477-82. PubMed ID: 18312761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
